Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Muir

Showing results (451-460 of 494) with videos related to

Pageof 50
Sort By:
Neuroscience Letters|May 4, 2010
Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorderRosie M Walker, Andrea Christoforou, Pippa A Thomson, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|October 17, 2024
Challenges in assessing the effects of environmental governance systems on conservation outcomesRaphael A Ayambire, Trina Rytwinski, Jessica J Taylor, et al.
Psychiatric Genetics|April 23, 2010
Support for a bipolar affective disorder susceptibility locus on chromosome 12q24.3Henriette Nørmølle Buttenschøn, Henriette Nørmølle Buttenchøn, Leslie Foldager, et al.
Genomics|February 15, 2001
A 6.9-Mb high-resolution BAC/PAC contig of human 4p15.3-p16.1, a candidate region for bipolar affective disorderK L Evans, S Le Hellard, S W Morris, et al.
Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.
Journal of Hepatology|October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trialGregory J Dore, Jordan J Feld, Alex Thompson, et al.
Journal of Hepatology|November 12, 2018
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trialGideon M Hirschfield, Olivier Chazouillères, Joost P Drenth, et al.
Hepatology (Baltimore, Md.)|April 18, 2019
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab TrialsArun J Sanyal, Stephen A Harrison, Vlad Ratziu, et al.
Gastroenterology|October 12, 2014
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantationMichael Charlton, Edward Gane, Michael P Manns, et al.
Hepatology (Baltimore, Md.)|August 29, 2018
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the DiseaseAndrew J Muir, Cynthia Levy, Harry L A Janssen, et al.
Pageof 50

Showing results (451-460 of 494) with videos related to

Sort By:
Pageof 50
Neuroscience Letters|May 4, 2010
Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorderRosie M Walker, Andrea Christoforou, Pippa A Thomson, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|October 17, 2024
Challenges in assessing the effects of environmental governance systems on conservation outcomesRaphael A Ayambire, Trina Rytwinski, Jessica J Taylor, et al.
Psychiatric Genetics|April 23, 2010
Support for a bipolar affective disorder susceptibility locus on chromosome 12q24.3Henriette Nørmølle Buttenschøn, Henriette Nørmølle Buttenchøn, Leslie Foldager, et al.
Genomics|February 15, 2001
A 6.9-Mb high-resolution BAC/PAC contig of human 4p15.3-p16.1, a candidate region for bipolar affective disorderK L Evans, S Le Hellard, S W Morris, et al.
Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.
Journal of Hepatology|October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trialGregory J Dore, Jordan J Feld, Alex Thompson, et al.
Journal of Hepatology|November 12, 2018
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trialGideon M Hirschfield, Olivier Chazouillères, Joost P Drenth, et al.
Hepatology (Baltimore, Md.)|April 18, 2019
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab TrialsArun J Sanyal, Stephen A Harrison, Vlad Ratziu, et al.
Gastroenterology|October 12, 2014
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantationMichael Charlton, Edward Gane, Michael P Manns, et al.
Hepatology (Baltimore, Md.)|August 29, 2018
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the DiseaseAndrew J Muir, Cynthia Levy, Harry L A Janssen, et al.
Pageof 50